Dublin, Oct. 26, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Connected Drug Delivery - Devices, Markets, Players, Strategies and Forecasts" report to their offering.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.

Connected devices - drug delivery devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

What You Will Learn

• What drug delivery devices incorporate connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
• What benefits do connected drug delivery devices provide to patients in the area of improved adherence? Patient safety and reported outcomes? HCP/patient communication?
• What therapeutic areas are the current focus of connected devices?
• Who are the companies behind the push to connected delivery devices? What are their development activities and corporate alliances and affiliations?
• What is the importance of pharma-device alliances and design partnerships on connected drug delivery device commercialization and market access?
• What does the current market for connected drug delivery devices look like? What will it look like in 2020?
• What are the key market drivers for the growth of connected drug delivery devices?

Key Topics Covered:

1. Executive Summary

2. Connected Devices - The Opportunity

• Drug Development Trends
• The Rapid Rise of Prefilled Devices
• Factors Driving Drug Self-Administration
• Therapeutic Demand Drivers
• The Impact of Developing Economies

3. Wireless Connectivity Technologies

• Bluetooth
• Cellular
• Near Field Communications
• Emerging Technologies

4. Wirelessly Connected Device Analysis

• Inhalation
• Integrated Connected Devices
• Third Party/Aftermarket Connectivity Devices
• Injection
• Connected Handheld Injection Devices
• Connected Wearable Injection Devices
• Vendor-specific Connectivity Platforms
• Third Party Connectivity Devices
• Solid Dosage Forms
• Transdermal Systems

5. Near-term Markets and Applications

• Addiction
• Anaphylaxis
• Autoimmune Diseases
• Cardiovascular
• Diabetes
• Hormone Replacement
• Neurology
• Upper Respiratory Diseases

6. Market Factors

• Regulatory Requirements
• Data Security
• Patient Acceptance and Training

7. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/92gk5t/connected_drug

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Drug Delivery

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.